This study develops an analytical model on the impact of corporate financialization and corporate R&D expenditure based on the micro perspective of firms, and uses data from A-share listed companies to test and assess the fixed-effect model and IV-GMM test, respectively. The findings indicate that business financialization has a considerable negative impact on company R&D investment, and that as corporate financialization levels rise, corporate.
No takes yet. Share an insight, caveat, or question.
Yao Yuan (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: